We have observed
6 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after February 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
MODULATORS OF C3A RECEPTORS
PROTEIN EXPRESSION ENHANCING POLYPEPTIDES
SALT PRODUCTS COATED WITH NATURAL AMINO ACIDS EXTRACTS FOR SODIUM INTAKE REDUCTION
LACTATE PRODUCTION PROCESS
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASES CONTAINING FLUOXETINE AND VITAMIN C AS ACTIVE INGREDIENTS
POLYPORUS SQUAMOSUS-DERIVED RECOMBINANT LECTIN SPECIFIC FOR SIALIC ACID LINKAGE